N-Acetyl cysteine effectively alleviates Coxsackievirus B-Induced myocarditis through suppressing viral replication

Yao Wang1, Shuoxuan Zhao1, Yang Chen2

  • 1Department of Cell Biology, Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.

Antiviral Research
|December 30, 2019
PubMed

Insights

N-acetyl cysteine (NAC) effectively treats viral myocarditis by inhibiting caspase-1 activation, reducing Coxsackievirus B replication and inflammation. This clinically approved drug offers a promising therapy for heart inflammation.

Area of Science:

  • Virology
  • Immunology
  • Cardiology

Background:

  • Viral myocarditis, often caused by Coxsackievirus B (CVB), leads to severe myocardial inflammation, potentially progressing to heart failure.
  • Current treatments for viral myocarditis are limited, highlighting the need for effective therapeutic agents.
  • Previous research indicated that inhibiting caspase-1 activation suppresses CVB replication.

Purpose of the Study:

  • To investigate the therapeutic potential of N-acetyl cysteine (NAC) in treating CVB-induced viral myocarditis.
  • To elucidate the mechanisms underlying NAC's antiviral and anti-inflammatory effects in the context of CVB infection.

Main Methods:

  • In vivo studies using a mouse model of CVB type 3 (CVB3) infection.
  • In vitro cell culture experiments to assess NAC's effects on viral replication and inflammatory markers.
  • Analysis of caspase-1 activation, procaspase-1 degradation via the ubiquitin-proteasome system, and viral protease activity.

Main Results:

  • NAC significantly alleviated myocardial injury in CVB3-infected mice.
  • NAC suppressed both CVB replication and inflammatory responses in the myocardium and cell cultures.
  • NAC's therapeutic effects were mediated by the inhibition of caspase-1 activation, independent of its antioxidant properties, and by inhibiting viral proteases.

Conclusions:

  • N-acetyl cysteine (NAC) demonstrates potent antiviral and anti-inflammatory effects against Coxsackievirus B by targeting caspase-1 activation.
  • NAC promotes procaspase-1 degradation and inhibits viral proteases, contributing to its therapeutic efficacy.
  • Given its clinical approval and demonstrated efficacy, NAC is recommended as a potential therapeutic agent for viral myocarditis.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
136
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
298
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
169
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
204
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
176
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
308